Detection of Recurrent Non-Hodgkin Lymphoma on In-111 Capromab Pendetide Imaging. (July 2015)

• Record Type: Journal Article
• Authors: Franc, Benjamin L.; Lin, Hank
• Is Part Of: Clinical nuclear medicine. Volume 40:Number 7(2015)
• Publication Date: 2015-07
• Subjects: SPECT/CT -- prostate cancer -- antibody imaging; Nuclear medicine -- Periodicals; Radioisotope scanning -- Periodicals; Nuclear Medicine -- Periodicals; 616.07575
• DOI: 10.1097/RLU.0000000000000782
• Languages: English
• ISSNs: 0363-9762

Abstract

Abstract : Abstract: A 73-year-old man presented with a rising prostate-specific antigen (PSA) level 5 years following brachytherapy for prostate cancer. In-111 capromab pendetide (ProstaScint) whole-body planar imaging revealed abnormal uptake in the right knee, localizing to a mass in the popliteal fossa on SPECT/CT. MRI showed a mass encasing the popliteal artery and vein, subsequently found to be non-Hodgkin lymphoma on biopsy. Response of the mass to chemotherapy was documented on 18 F-FDG PET/CT. Elevated In-111 capromab pendetide uptake in soft tissue can be important but unrelated to prostate cancer, as demonstrated in this case.